211 related articles for article (PubMed ID: 26200037)
21. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.
Balta I; Balta S; Demirkol S; Mikhailidis DP; Celik T; Akhan M; Kurt O; Kurt YG; Aydin I; Kilic S
Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284
[TBL] [Abstract][Full Text] [Related]
22. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
[TBL] [Abstract][Full Text] [Related]
23. Endocan Concentration in Patients With Primary Hypertension.
Musialowska D; Zbroch E; Koc-Zorawska E; Musialowski P; Malyszko J
Angiology; 2018 Jul; 69(6):483-489. PubMed ID: 29084442
[TBL] [Abstract][Full Text] [Related]
24. Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study.
Karabakan M; Bozkurt A; Akdemir S; Gunay M; Keskin E
Int J Impot Res; 2017 Jul; 29(4):175-178. PubMed ID: 28424502
[TBL] [Abstract][Full Text] [Related]
25. Higher Serum Endocan Level Is Associated with Alzheimer Disease.
Varan HD; Guner G; Kizilarslanoglu MC; Sumer F; Dogrul RT; Sagir A; Ozsurekci C; Caliskan H; Balci C; Aycicek GS; Akbiyik F; Halil M; Cankurtaran M; Yavuz BB
Dement Geriatr Cogn Disord; 2017; 44(5-6):303-310. PubMed ID: 29393258
[TBL] [Abstract][Full Text] [Related]
26. Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
Ağaç MT; Kahyaoğlu B; Aksoy MMN; Cinemre FB; Vatan MB; Gündüz Y
Anatol J Cardiol; 2019 Feb; 21(2):76-82. PubMed ID: 30694799
[TBL] [Abstract][Full Text] [Related]
27. Endocan as a marker of disease severity in pulmonary thromboembolism.
Kuluöztürk M; İn E; İlhan N
Clin Respir J; 2019 Dec; 13(12):773-780. PubMed ID: 31556240
[TBL] [Abstract][Full Text] [Related]
28. Serum endocan levels in patients with cardiac syndrome X.
Efe SC; Demirci K; Ozturk S; Gurbuz AS; Poci N; Kilicgedik A; Guler A; Yilmaz MF; İzgi IA; Kirma C
Herz; 2018 Jun; 43(4):359-363. PubMed ID: 28589439
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
[TBL] [Abstract][Full Text] [Related]
30. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim.
Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H
Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498
[TBL] [Abstract][Full Text] [Related]
31. Serum salusin-β levels are associated with the presence and severity of coronary artery disease.
Liu J; Ren YG; Zhang LH; Tong YW; Kang L
J Investig Med; 2015 Apr; 63(4):632-5. PubMed ID: 25730454
[TBL] [Abstract][Full Text] [Related]
32. Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.
Oka S; Obata Y; Sato S; Torigoe K; Sawa M; Abe S; Muta K; Ota Y; Kitamura M; Kawasaki S; Hirose M; Uramatsu T; Mukae H; Nishino T
Med Sci Monit; 2017 Mar; 23():1464-1470. PubMed ID: 28343234
[TBL] [Abstract][Full Text] [Related]
33. Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea.
Sun H; Fang F; Li K; Zhang H; Zhang M; Zhang L; Li J; Qin Y; Wei Y
Respir Res; 2019 Aug; 20(1):188. PubMed ID: 31429753
[TBL] [Abstract][Full Text] [Related]
34. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.
Elkamshoushi AM; Omar SS; El Abd AM; Hassan SZ; Sultan EA; Abd Elkawy E
Int J Dermatol; 2019 Apr; 58(4):456-464. PubMed ID: 30471086
[TBL] [Abstract][Full Text] [Related]
35. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.
Dallio M; Masarone M; Caprio GG; Di Sarno R; Tuccillo C; Sasso FC; Persico M; Loguercio C; Federico A
J Gastrointestin Liver Dis; 2017 Sep; 26(3):261-268. PubMed ID: 28922438
[TBL] [Abstract][Full Text] [Related]
36. Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.
Bouglé A; Allain PA; Favard S; Ait Hamou N; Carillion A; Leprince P; Granger B; Amour J
Anaesth Crit Care Pain Med; 2018 Dec; 37(6):565-570. PubMed ID: 29476941
[TBL] [Abstract][Full Text] [Related]
37. Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?
Onuk Ö; Arslan B; Gezmis TC; Çetin B; Göv T; Yazıcı G; Gürkan O; Ozdemir E
Int Urol Nephrol; 2018 Sep; 50(9):1577-1582. PubMed ID: 30054863
[TBL] [Abstract][Full Text] [Related]
38. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
Pawlak K; Mysliwiec M; Pawlak D
Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
[TBL] [Abstract][Full Text] [Related]
39. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.
Elkamshoushi AAM; Hassan EM; El Abd AM; Hassan SZ; Maher AA
Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584
[TBL] [Abstract][Full Text] [Related]
40. Endocan, a new endothelial marker in human sepsis.
Scherpereel A; Depontieu F; Grigoriu B; Cavestri B; Tsicopoulos A; Gentina T; Jourdain M; Pugin J; Tonnel AB; Lassalle P
Crit Care Med; 2006 Feb; 34(2):532-7. PubMed ID: 16424738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
